Beth C. Seidenberg - 18 May 2021 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Director
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
18 May 2021
Net transactions value
$0
Form type
4
Filing time
18 May 2021, 20:15:58 UTC
Previous filing
17 May 2021
Next filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Conversion of derivative security +423,642 423,642 18 May 2021 See footnote F1, F2
transaction VERA Class A Common Stock Conversion of derivative security +100,526 +24% 524,168 18 May 2021 See footnote F3, F4
transaction VERA Class A Common Stock Conversion of derivative security +818,984 +156% 1,343,152 18 May 2021 See footnote F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Series A Preferred Stock Conversion of derivative security $0 -423,642 -100% $0.000000* 0 18 May 2021 Class A Common Stock 423,642 See footnote F1, F7
transaction VERA Series B Preferred Stock Conversion of derivative security $0 -100,526 -100% $0.000000* 0 18 May 2021 Class A Common Stock 100,526 See footnote F3, F8
transaction VERA Series C Preferred Stock Conversion of derivative security $0 -818,984 -100% $0.000000* 0 18 May 2021 Class A Common Stock 818,984 See footnote F5, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
F2 Consists of 409,620 shares of Class A Common Stock held by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 14,022 shares of Class A Common Stock held by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.
F3 The Series B Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
F4 Consists of 506,819 shares of Class A Common Stock held by KPCB XVI and 17,349 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.
F5 The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
F6 Consists of 1,298,695 shares of Class A Common Stock held by KPCB XVI and 44,457 shares of Class A Common Stock held by XVI Founders. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI is XVI Associates. L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of KPCB XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI except to the extent of their pecuniary interest therein.
F7 Consisted of 409,620 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by KPCB XVI and 14,022 shares of Class A Common Stock that was automatically converted from the Issuer's Series A Preferred Stock held by XVI Founders.
F8 Consisted of 97,199 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by KPCB XVI and 3,327 shares of Class A Common Stock that was automatically converted from the Issuer's Series B Preferred Stock held by XVI Founders.
F9 Consisted of 791,876 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by KPCB XVI and 27,108 shares of Class A Common Stock that was automatically converted from the Issuer's Series C Preferred Stock held by XVI Founders.